THE PANCREATIC CANCER ACTION NETWORK, along with advocates and survivors, gathered on Capitol Hill this week to urge Congress to fund federal cancer research. “To ensure Congress continues to make cancer research funding a priority, we need even more committed individuals to join our efforts,” said Julie Fleshman, president and CEO of the Pancreatic Cancer...
Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019).
